250 participants enrolled in less than five months from first participant dosing, representing the fastest site activation and enrolment in the HEALEY ALS Platform Trial so far Anticipated topline efficacy and safety results for NUZ-001 now expected in late Q2 CY2027 Completion of recruitment materially de-risks execution of Neurizon's lead late-stage clinical program Reflects strong recruitment and effective execution across the HEALEY ALS Platform Trial network Participants now progressing through the planned 36-week randomised treatment period MELBOURNE, Australia , 16 July 2026 /PRNewswire/ -- Neurizon® Therapeutics Limited (ASX: NUZ; OTCQB: NUZTF) ("Neurizon" or "the Company"), a late-stage clinical biotechnology company dedicated to advancing innovative treatments for neurodegenerative diseases, is pleased to advise that enrolment has been completed in Regimen I of the Phase 2/3 HEALEY ALS Platform Trial evaluating the Company's lead investigational therapy NUZ-001 for the treatment of amyotrophic lateral sclerosis (ALS).
×
Javascript is required for you to be able to read premium content. Please enable it in your browser settings.
kA 4=2DDlQAC?E2=Qm}6FC:K@? 25G:D6D E92E E96 7:?2= A2CE:4:A2?E 92D 4@>A=6E65 E96:C 32D6=:?6 G:D:E 2?5 4@>>6?465 EC62E>6?E[ 4@>A=6E:?8 6?C@=>6?E :?E@ #68:>6? x] #67=64E:?8 E96 C2A:5 A246 @7 C64CF:E>6?E[ E96 r@>A2?J ?@H 6IA64ED E@ C6A@CE E@A=:?6 677:424J 2?5 D276EJ C6DF=ED :? =2E6 "a r*a_af[ 62C=:6C E92? AC6G:@FD=J 2?E:4:A2E65]k^Am
kA 4=2DDlQAC?E2=Qmr@>A=6E:@? @7 6?C@=>6?E[ E@86E96C H:E9 E96 62C=:6C 2?E:4:A2E65 E:>:?8 @7 E96 E@A=:?6 C6DF=ED C625@FE[ 7FCE96C 56>@?DEC2E6D E96 4@?E:?F65 25G2?46>6?E @7 E96 =2E6\DE286 4=:?:42= 56G6=@A>6?E AC@8C2> 7@C }&+\__` 7@C E96 EC62E>6?E @7 p{$] #68:>6? x 4@>A=6E65Â 6?C@=>6?E :? =6DD E92? 7:G6 >@?E9D 7C@> 7:CDE A2CE:4:A2?E 5@D:?8[ 364@>:?8 E96 72DE6DE C68:>6? E@ 24E:G2E6 D:E6D 2?5 4@>A=6E6 6?C@=>6?E :? E96 wtp{t* p{$ !=2E7@C> %C:2=[ 6G6? 27E6C E96 A=2??65 D2>A=6 D:K6 6IA2?D:@? 7C@> `e_ E@ ac_ A2CE:4:A2?ED :? C6DA@?D6 E@ DEC@?8 C64CF:E>6?E >@>6?EF>]k^Am
kA 4=2DDlQAC?E2=Qm%9:D 249:6G6>6?E C67=64ED E96 DEC6?8E9 @7 C64CF:E>6?E 24C@DD E96 wtp{t* p{$ !=2E7@C> %C:2= ?6EH@C<[ @?6 @7 E96 H@C=5VD =625:?8 p{$ 4=:?:42= EC:2= :?:E:2E:G6D[ E96 @A6C2E:@?2= 677:4:6?4:6D :?EC@5F465 F?56C E96 EC:2=VD ?6IE 86?6C2E:@? >2DE6C AC@E@4@=[ 2?5 E96 4@>>:E>6?E @7 :?G6DE:82E@CD[ C6D62C49 4@@C5:?2E@CD 2?5 4=:?:42= D:E6 E62>D 24C@DD E96 &?:E65 $E2E6D]Â k^Am
kA 4=2DDlQAC?E2=Qm}6FC:K@? D:?46C6=J 24<?@H=6586D 6G6CJ A6CD@? =:G:?8 H:E9 p{$ 2?5 E96:C 72>:=:6D H9@ 92D 49@D6? E@ A2CE:4:A2E6 :? E9:D C6D62C49[ C64@8?:D:?8 E92E E96:C 4@>>:E>6?E :D 7F?52>6?E2= E@ 25G2?4:?8 4=:?:42= C6D62C49 2?5 E96 56G6=@A>6?E @7 A@E6?E:2= ?6H EC62E>6?E @AE:@?D 7@C E96 p{$ 4@>>F?:EJ]k^Am
kA 4=2DDlQAC?E2=Qm!2CE:4:A2?ED H:== ?@H 4@?E:?F6 E9C@F89 E96 be\H66< #2?5@>:D65 r@?EC@==65 %C:2= A92D6 367@C6 6?E6C:?8 E96 be\H66< p4E:G6 %C62E>6?E tIE6?D:@? A92D6[ H:E9 E96 r@>A2?JVD 7@4FD 46?EC65 @? 4@?E:?F65 6I64FE:@? 29625 @7 E96 2?E:4:A2E65 E@A=:?6 C625@FE :? =2E6 "a r*a_af]k^Am
kA 4=2DDlQAC?E2=QmkDEC@?8mx?E6C:> tI64FE:G6 r92:C>2?[ |C $6C8:@ sF49:?: D2:5ik^DEC@?8m Qr@>A=6E:@? @7 6?C@=>6?E C6AC6D6?ED 2 >2;@C >:=6DE@?6 :? E96 4=:?:42= 56G6=@A>6?E @7 }&+\__`] x>A@CE2?E=J[ E96 C2A:5 4@>A=6E:@? @7 C64CF:E>6?E 92D 6?23=65 E96 2?E:4:A2E65 E:>:?8 @7 E@A=:?6 677:424J 2?5 D276EJ C6DF=ED E@ 36 2446=6C2E65 :?E@ =2E6 "a r*a_af[ 3C:?8:?8 7@CH2C5 2? :>A@CE2?E G2=F6 :?7=64E:@? A@:?E 7@C }6FC:K@? 2?5 @FC D92C69@=56CD]k^Am
kA 4=2DDlQAC?E2=Qm~? 3692=7 @7 E96 r@>A2?J[ x H@F=5 =:<6 E@ D:?46C6=J E92?< 6G6CJ A6CD@? =:G:?8 H:E9 p{$ 2?5 E96:C 72>:=:6D H9@ 49@D6 E@ A2CE:4:A2E6 :? E9:D EC:2=] %96:C H:==:?8?6DD E@ 4@?EC:3FE6 E@ C6D62C49 56DA:E6 E96 :>>6?D6 492==6?86D @7 E9:D 5:D62D6 :D :?DA:C:?8 2?5 :D 7F?52>6?E2= E@ 25G2?4:?8 E96 56G6=@A>6?E @7 ?6H EC62E>6?E @AE:@?D 7@C A6@A=6 =:G:?8 H:E9 p{$]k^Am
kA 4=2DDlQAC?E2=Qmx H@F=5 2=D@ =:<6 E@ 24<?@H=6586 E96 @FEDE2?5:?8 H@C< @7 E96 wtp{t* p{$ !=2E7@C> %C:2= E62>[ :?G6DE:82E@CD[ C6D62C49 4@@C5:?2E@CD 2?5 4=:?:42= D:E6 E62>D H9@D6 6IA6CE:D6[ 4@==23@C2E:@? 2?5 4@>>:E>6?E 92G6 >256 E9:D 249:6G6>6?E A@DD:3=6]k^Am
kA 4=2DDlQAC?E2=Qm(:E9 C64CF:E>6?E ?@H 4@>A=6E6[ @FC 7@4FD EFC?D E@ 56=:G6C:?8 E96 DEF5J H:E9 E96 D2>6 @A6C2E:@?2= 5:D4:A=:?6 E92E 92D 492C24E6C:D65 E96 AC@8C2> E@ 52E6] (6 =@@< 7@CH2C5 E@ 25G2?4:?8 }&+\__` E9C@F89 4=:?:42= 56G6=@A>6?E 2?5 E@H2C5D E96 2?E:4:A2E65 E@A=:?6 677:424J 2?5 D276EJ C6DF=ED]Qk^Am
kA 4=2DDlQAC?E2=QmkDEC@?8ms:C64E@C @7 E96 $62? |] w62=6J U2>Aj p|v r6?E6C 2?5 tI64FE:G6 s:C64E@C @7 E96 |2DD v6?6C2= qC:892> }6FC@D4:6?46 x?DE:EFE6[ |6C:E rF5<@H:4K[ |s[ |$4 D2:5k^DEC@?8mi Q(6 2C6 8C2E67F= E@ 6G6CJ@?6 H9@ 96=A65 4@>A=6E6 6?C@=>6?E :? #68:>6? x :? DF49 2 D9@CE 2>@F?E @7 E:>6] (6 36=:6G6 DEC@?8=J :? :>A@CE2?46 @7 DA665[ 677:4:6?4J 2?5 9:89 BF2=:EJ :? 4=:?:42= EC:2=D] ~FC A2E:6?ED E6== FD E92E E96 p{$ 4=@4< :D 72DE6C 2?5 H6 ?665 E@ H@C< 4@==23@C2E:G6=J E@ 56G6=@A EC62E>6?ED D@@?6C] %9:D :D @?6 @7 E96 8F:5:?8 AC:?4:A=6D @7 E96 w62=6J p{$ !=2E7@C> %C:2=[ }6IE v6?6C2E:@?] %96 C2A:5 DA665 @7 6?C@=>6?E :? E9:D C68:>6? :D 2 E6DE2>6?E E@ E96 92C5 H@C< @7 A2CE:4:A2?ED 2?5 E96:C 72>:=:6D 2?5 DEF5J DE277 24C@DD 2== E96 A2CE:4:A2E:?8 }tp{$ D:E6D[ 2D H6== 2D E@ E96 @AE:>:D65 !=2E7@C> %C:2= :?7C2DECF4EFC6]Qk^Am
kA 4=2DDlQAC?E2=QmkDEC@?8mp3@FE E96 wtp{t* p{$ !=2E7@C> %C:2=ik^DEC@?8mk^Am
kA 4=2DDlQAC?E2=Qm%96 wtp{t* p{$ !=2E7@C> %C:2= Wr=:?:42=%C:2=D]8@G :56?E:7:6Ci }r%_cahfegbX :D 2 >F=E:46?EC6[ 5@F3=6\3=:?5[ A=2463@ 4@?EC@==65 252AE:G6 !92D6 a^b 4=:?:42= EC:2= 4@?5F4E65 3J E96 $62? |] w62=6J U2>Aj p|v r6?E6C 7@C p{$ 2E |2DD v6?6C2= qC:892> :? E96 &?:E65 $E2E6D W&$X[ 4C62E65 :? A2CE?6CD9:A H:E9 E96 }6EH@C< @7 tI46==6?46 7@C p{$ W}tp{$X] t?ECJ :?E@ E96 wtp{t* p{$ !=2E7@C> %C:2= :D 4@>A6E:E:G6[ H:E9 5CF8 42?5:52E6D C6G:6H65 2?5 D6=64E65 3J 6IA6CE 4@>>:EE66D 32D65 @? D4:6?E:7:4 >6C:E 2?5 6G:56?46 @7 A@E6?E:2= 36?67:E :? p{$] %96 8@2= @7 E96 wtp{t* p{$ !=2E7@C> %C:2= :D E@ 2446=6C2E6 E96 56G6=@A>6?E @7 A@E6?E:2= ?6H p{$ E96C2A:6D]k^Am
kA 4=2DDlQAC?E24Qm\t}s$\k^Am
kA 4=2DDlQAC?E2=Qm%9:D 2??@F?46>6?E 92D 366? 2FE9@C:D65 7@C C6=62D6 3J E96 q@2C5 @7 }6FC:K@? %96C2A6FE:4D {:>:E65]k^Am
kA 4=2DDlQAC?E2=QmkDEC@?8mp3@FE }6FC:K@? %96C2A6FE:4D {:>:E65k^DEC@?8mk^Am
kA 4=2DDlQAC?E2=Qm}6FC:K@? %96C2A6FE:4D {:>:E65 Wp$)i }&+X :D 2 =2E6\DE286 4=:?:42= 3:@E649?@=@8J 4@>A2?J 565:42E65 E@ 25G2?4:?8 EC62E>6?ED 7@C ?6FC@5686?6C2E:G6 5:D62D6D] }6FC:K@? :D 56G6=@A:?8 :ED =625 5CF8 42?5:52E6[ }&+\__`[ 7@C E96 EC62E>6?E @7 p{$[ H9:49 :D E96 >@DE 4@>>@? 7@C> @7 >@E@C ?6FC@?6 5:D62D6]Â }6FC:K@?VD DEC2E68J :D E@ 2446=6C2E6 2446DD E@ 67764E:G6 p{$ EC62E>6?ED 7@C A2E:6?ED H9:=6 6IA=@C:?8 E96 A@E6?E:2= @7 }&+\__` 7@C 3C@256C ?6FC@5686?6C2E:G6 2AA=:42E:@?D] %9C@F89 :?E6C?2E:@?2= 4@==23@C2E:@?D 2?5 C:8@C@FD 4=:?:42= AC@8C2>D[ }6FC:K@? :D 565:42E65 E@ 4C62E:?8 ?6H 9@C:K@?D 7@C A2E:6?ED 2?5 72>:=:6D :>A24E65 3J 4@>A=6I ?6FC2= 5:D@C56CD] }&+\__` :D 2? :?G6DE:82E:@?2= AC@5F4E 2?5 :D ?@E 2AAC@G65 7@C 4@>>6C4:2= FD6 :? 2?J ;FC:D5:4E:@?]k^Am
kAmkDEC@?8m}6FC:K@? x?G6DE@C wF3k^DEC@?8mk^Am
kAm(6 6?4@FC286 J@F E@ FE:=:D6 @FC x?G6DE@C wF3 7@C 2?J 6?BF:C:6D C682C5:?8 E9:D 2??@F?46>6?E @C @E96C 2DA64ED 4@?46C?:?8 }6FC:K@?]k^Am
kAm%9:D A=2E7@C> @776CD 2? @AA@CEF?:EJ E@ DF3>:E BF6DE:@?D[ D92C6 4@>>6?ED[ 2?5 G:6H G:56@ DF>>2C:6D @7 <6J 2??@F?46>6?ED]k^Am
kAm%@ 2446DD }6FC:K@? x?G6DE@C wF3 kDA2? :5lQDA2?w89=E5aedQmA=62D6Â G:D:Ek^DA2?m k2 9C67lQ9EEADi^^:?G6DE@C9F3]?6FC:K@?]4@>^Q E2C86ElQ03=2?<Q C6=lQ?@7@==@HQm9EEADi^^:?G6DE@C9F3]?6FC:K@?]4@>k^2mk^Am
kAm}6FC:K@?® :D 2 C68:DE6C65 EC256>2C< @7 }6FC:K@? %96C2A6FE:4D {:>:E65kDA2? :5lQDA2?w89=Ec3geQm]k^DA2?mk^Am
kA 4=2DDlQAC?E2=Qm k^Am
kA :5lQ!&#{Qmk:>8 E:E=6lQr:D:@?Q H:5E9lQ`aQ 96:89ElQ`aQ 2=ElQr:D:@?Q DC4lQ9EEADi^^6586]AC?6HDH:C6]4@>^4^:>8^72G:4@?]A?8nD?lr}_efgfU2>AjD5la_ae\_f\`eQ ^m ':6H @C:8:?2= 4@?E6?Eik2 :5lQ!#}&#{Q C6=lQ?@7@==@HQ 9C67lQ9EEADi^^HHH]AC?6HDH:C6]4@>^?6HD\C6=62D6D^962=6J\2=D\A=2E7@C>\EC:2=\C68:>6?\:\6?C@=>6?E\4@>A=6E65\\E@A=:?6\C6DF=ED\7@C\?FK\__`\2446=6C2E65\E@\Ba\4Ja_af\b_agagacg]9E>=Q E2C86ElQ03=2?<Qm9EEADi^^HHH]AC?6HDH:C6]4@>^?6HD\C6=62D6D^962=6J\2=D\A=2E7@C>\EC:2=\C68:>6?\:\6?C@=>6?E\4@>A=6E65\\E@A=:?6\C6DF=ED\7@C\?FK\__`\2446=6C2E65\E@\Ba\4Ja_af\b_agagacg]9E>=k^2mk^Am
kAm$~&#rt }6FC:K@? %96C2A6FE:4D {:>:E65k^Am
kAmk:>8 2=ElQQ DC4lQ9EEADi^^CE]AC?6HDH:C6]4@>^CE]8:7n}6HDxE6>x5lr}_efgfU2>Aj%C2?D>:DD:@?0x5la_ae_f`eabcg!#0}t($0&$!#00000r}_efgfU2>Ajs2E6x5la_ae_f`eQ DEJ=6lQ3@C56Ci_AIj H:5E9i`AIj 96:89Ei`AIjQ ^mk^Am
(0) comments
Welcome to the discussion.
Log In
Keep it Clean. Please avoid obscene, vulgar, lewd, racist or sexually-oriented language.
PLEASE TURN OFF YOUR CAPS LOCK.
Don't Threaten. Threats of harming another person will not be tolerated.
Be Truthful. Don't knowingly lie about anyone or anything.
Be Nice. No racism, sexism or any sort of -ism that is degrading to another person.
Be Proactive. Use the 'Report' link on each comment to let us know of abusive posts.
Share with Us. We'd love to hear eyewitness accounts, the history behind an article.